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Background: Despite persistent calls to measure the effectiveness of educational interventions on patient outcomes,
few studies have been conducted. Within musculoskeletal physiotherapy, the effects of postgraduate clinical mentoring
on physiotherapist performance have been assessed, but the impact of this mentoring on patient outcomes remains
unknown. The objective of this trial is to assess the effectiveness of a work-based mentoring programme to facilitate
physiotherapist clinical reasoning on patient outcomes in musculoskeletal physiotherapy.
Methods/Design: A stepped wedge cluster randomised controlled trial (CRCT) has been designed to recruit a
minimum of 12 senior physiotherapists who work in musculoskeletal outpatient departments of a large National
Health Service (NHS) organization. Participating physiotherapists will be randomised by cluster to receive the
intervention at three time periods. Patients will be blinded to whether their physiotherapist has received the
intervention. The primary outcome measure will be the Patient-Specific Functional Scale; secondary outcome measures
will include the EQ-5D, patient activation, patient satisfaction and physiotherapist performance. Sample size
considerations used published methods describing stepped wedge designs, conventional values of 0.80 for
statistical power and 0.05 for statistical significance, and pragmatic groupings of 12 participating physiotherapists
in three clusters. Based on an intergroup difference of 1.0 on the PSFS with a standard deviation of 2.0, 10 patients are
required to complete outcome measures per physiotherapist, at time period 1 (prior to intervention roll-out) and at
each of time periods 2, 3 and 4, giving a sample size of 480 patients. To account for the potential loss to follow-up of
33%, 720 sets of patient outcomes will be collected.
All physiotherapist participants will receive 150 hours of mentored clinical practice as the intervention and usual
in-service training as control. Consecutive, consenting patients attending treatment by the participating physiotherapists
during data collection periods will complete outcome measures at baseline, discharge and 12 months post-baseline. The
lead researcher will be blinded to the allocation of the physiotherapist when analyzing outcome data; statistical analysis
will involve classical linear models incorporating both an intervention effect and a random intercept term to reflect
systematic differences among clusters.
Trial registration: Assigned 31 July 2012: ISRCTN79599220.
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Outcomes research has been defined as the assessment
of what does and does not work in the delivery of
healthcare [1]. While a large volume of research has
focussed on examining the effect of different treatment
regimes on patient outcomes, it has been widely acknowl-
edged that the clinician delivering treatment is an integral
component of the intervention and that the interpersonal
interactions between clinician and patient may have strong
influences on outcomes [2-6]. This has led for calls to
research the nature, type and extent of these interpersonal
factors and to assess the degree to which changes in these
factors can achieve better patient outcomes [2,4]. It is also
argued by researchers from within medical education that
the education and development of clinicians should be
evaluated in order to ascertain whether they achieve better
health outcomes [1,7-11]. Such evaluation would enable
researchers to delineate how healthcare education contrib-
utes directly to the health of individuals and the public,
improves the relevance and impact of medical education
research, and enables patients and practitioners to make
better-informed, cost-effective healthcare decisions [1,10].
However, this type of research presents challenges,
particularly in view of the multiple factors - physical,
psychosocial, economic, environmental and cultural -
that can influence patient outcomes [7,12,13]. Disap-
pointingly, the call for research to investigate the
effectiveness of educational interventions has been
largely unheeded to date as there is a dearth of litera-
ture examining the impact of professional education
on patient outcome [1,7,10,14-17].
A key focus of postgraduate healthcare and medical
education is that of expertise development [18-28]. The
study of clinical expertise in healthcare has often relied
on the assumption of experience being a critical factor
[29-31]. As a result, much research has been performed
with participating practitioners who have years of experi-
ence, or seniority, or who are expert by reputation
[32-35]. This assumption has, however, been challenged
in a study of expertise in musculoskeletal physiotherapy.
Resnik and Jensen [36] used clinical outcomes to define
expertise and were able to predict outcomes for patients
after linear modelling. They did this by performing a
retrospective analysis of health-related quality of life
outcome data to calculate mean patient outcomes for
each physiotherapist participating in an outcomes data-
base and by using a generalized linear model to control
for patient factors on outcomes such as patient age and
severity of condition. By examining the differences
between the actual and predicted outcome scores, an
‘expert group’ of therapists (the top 10% of therapists
whose patients had the highest mean outcome scores)
and an ‘average group’ of therapists (the 10% of thera-
pists whose patients had 45th to 55th percentile meanoutcome scores) were identified. No difference in the years
of clinical experience was found between these groups.
The same authors have argued that the key behaviours of
expertise can be identified, nurtured and taught [6,37-40],
and it therefore follows that if patient outcomes can be
used to identify expert clinicians, the development of
expertise within clinicians will contribute to improved
patient outcomes. While key behaviours of physiotherapy
expertise have been identified in qualitative studies, no
empirical evidence has supported the development of such
behaviours through education. However, interview data
from physiotherapists who were deemed experts in the
musculoskeletal field [36-38,41] identified that experts
attributed much of their development to working with
mentors who facilitated their clinical reasoning pro-
cesses: one of the identified behaviours of expert prac-
tice [36,38,39,42,43].
Clinical reasoning has been defined as a context-
dependent way of thinking and decision making in pro-
fessional practice that is used to guide practice actions
[44], and research evaluating expertise in physiotherapy
consistently identifies clinical reasoning as a critical
component [37,39,40,42,44-46]. Expert clinicians have
been shown to possess a broad scope of clinical reason-
ing strategies, and an ability to move between these
different clinical reasoning strategies seamlessly [45,47],
using inductive and deductive thinking, collaborating
throughout with their patients and informing - and being
informed by - their practice knowledge and intervention
strategies, ethical decisions and philosophies of practice
[37,38,41,42]. Experts’ clinical reasoning processes are able
to move from the biomedical aspects of the patient’s
presentations to the lived experience of that patient,
and from diagnostic inquiry to instrumental and com-
municative management [43,45]. In addition to studies
of expert practice, the importance of clinical reasoning has
been highlighted in work defining Master’s level clinical
practice in healthcare in the United Kingdom. A popu-
lation of tutors of all Master’s courses for healthcare
professionals in the UK prioritised a high level of clin-
ical reasoning skills as the most important behaviour for
the construct of Master’s level clinical practice [48]. A
high level of clinical reasoning skills as the most import-
ant behaviour was also identified in the subsequent
study of the construct validity of Master’s level muscu-
loskeletal physiotherapy [47]. Furthermore, a recent
study into the research priorities for postgraduate theses
in musculoskeletal physiotherapy internationally [49] −
involving a sample of course tutors and expert clinicians
nominated by Member Organizations of the International
Federation of Orthopaedic Manipulative Physical Ther-
apists (IFOMPT) - identified research questions investi-
gating clinical reasoning processes and skills amongst the
most important priorities. Authors in both the expertise
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to perform studies of clinical reasoning in natural clinical
settings [38,43,50-59]; therefore, research into the teaching
and nurturing of the key behaviours of expertise - of
which clinical reasoning is fundamental - should be set
within the clinical context.
Education in the clinical context is highlighted from
the small number of musculoskeletal studies that have
employed educational interventions and assessed the
clinical outcomes of patients treated by the participating
clinicians. These studies can be divided into two groups.
The first group of studies consist of cluster randomised
controlled trials (CRCTs) evaluating the effect of imple-
mentation of a specific treatment approach (for example,
new guideline approach to low back pain and psycho-
social model of care) compared to usual care. The
interventions all included education of the clinician
but did not measure the efficacy of the educational
programme per se; therefore, the evaluation of patient
outcome was a measure of the combination of the
treatment approach and the educational intervention.
These cluster RCTs also explore the strengths and
weaknesses of the educational interventions utilised.
Interestingly, the findings of this group of studies are
consistently disappointing in terms of impact on pa-
tient outcomes, and the authors frequently cite poten-
tial shortcomings in the education of the clinicians as a
possible reason for the failure of the intervention to be
more effective than usual care [60-64].
The second group of studies consists of two recent
trials that specifically evaluated educational approaches
using patient outcomes. Overmeer and colleagues [65,66]
investigated the impact of an 8-day university course for
physiotherapists aimed at identifying and addressing
psychosocial risk factors in patients with musculoskeletal
pain and their effect on patient outcome. Their trial
demonstrated that while the education programme
did elicit statistically significant changes in clinicians’
attitudes, beliefs and knowledge, there was no impact on
clinical patient outcomes, patient satisfaction, or percep-
tion of treatment [65]. Cleland and colleagues [67] investi-
gated the impact on patient outcomes of an educational
intervention to the treating physiotherapists. Clinical
outcomes were measured for separate groups of patients
treated by physiotherapists before and after a 2-day course
on the management of neck pain. After the course,
physiotherapists were randomised to intervention or
control. In the intervention group, physiotherapists
received ongoing education consisting of small group
sessions and an educational outreach session where they
received training in their clinical settings. The control
group received no further education. While the changes in
pain scores were not significantly different for patients
treated by the two groups of physiotherapists, reductionsin disability scores were significantly greater in patients
treated by physiotherapists who received the additional
ongoing training (mean difference of 4.2 points on the
Neck Disability Index, P =0.019). The patients in the
ongoing training group required a mean of 1.5 fewer
visits during the post-training period, which was also
statistically significant (P <0.001). While Cleland’s study
[67] did not control for some variables (such as prog-
nostic factors which could also have had an impact on
patient outcome) and had the potential for contamination
bias (physiotherapists from different groups worked in the
same clinics), it was the first to demonstrate the effective-
ness of an educational intervention on patient outcomes,
and this merits further consideration. The length of
training is cited as one potential reason for disappoint-
ing results in earlier studies [63], with time differences
varying from 2 hours [61] to 8 days [65]. Cleland’s study
[67] employed a 2-day course, two 1.5-hour meetings
within the following 4 to 7 weeks, and a clinical out-
reach visit (1-hour co-treatment of a patient) followed
by discussion, which is positioned between the two
extremes for length of training. Two distinguishing
features of Cleland et al.’s successful approach are that
the education programme was ongoing and included an
outreach visit with 1-hour co-treatment of an actual
patient with neck pain in the physiotherapist’s own
clinical practice setting. Overmeer and colleagues [65]
propose that ongoing education within the clinical context
may be the key element of an educational intervention,
on the premise that to improve patient outcomes,
changes in clinicians’ practice behaviour must result from
the received educational intervention. The authors went
on to suggest more explicitly that the educational strategy
most likely to change practice behaviour is to educate
the physiotherapist in the clinical environment and
to provide direct clinical feedback on the clinician’s
encounter with an actual patient.
This call for the delivery of education in the clinical
context has also been argued elsewhere within the
physiotherapy literature [68], in particular in Master’s
level education where mentoring in the clinical environ-
ment is used nationally and internationally to develop
clinical reasoning and other features of expert practice
[69]. The rationale for this approach is outlined in the
educational standards document of IFOMPT [69], a
non-governmental International Manipulative Physical
Therapy Federation representing international collabor-
ation in musculoskeletal physiotherapy that is a recog-
nised subgroup of the World Confederation for Physical
Therapy, which in turn is a part of the World Health
Organization (WHO). A minimum of 150 hours of
mentored clinical practice is recommended for students,
where the clinical mentor is a member of the Member
Organization of IFOMPT. Furthermore, this clinical
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in terms of its impact on physiotherapist performance and
career and is consistently evaluated as an effective com-
ponent of Master’s education on transforming practice
through multiple qualitative studies [27,28,47-49,70-73].
While the impact of this educational intervention has
been explored on the physiotherapist, its impact on
patient outcomes has not been investigated to date.
The objective of this trial is to assess the effectiveness
and cost-effectiveness of a work-based mentoring pro-
gramme for physiotherapists to facilitate clinical reason-
ing on patient outcomes in the field of musculoskeletal
physiotherapy on patient clinical outcome.
Methods/Design
A stepped-wedge design, a type of CRCT, has been
designed in line with the SPIRIT 2013 statement [74].
A CRCT was selected because of the nature of the
intervention and outcome. Educational interventions
lend themselves to CRCT evaluation on the basis that for
the training of clinicians to have an impact on their
patients’ outcomes is appropriately a cluster-level inter-
vention because education is frequently targeted at
departments or practices [75-77]. In this study, the
intervention will be applied at the cluster level to groups
of physiotherapists (by department) – see Figure 1. The
effect of the intervention on patient outcomes will also
require measurement on clusters of patients treated by
the physiotherapists before and after the intervention.
Clustering assists in preventing contamination. An indi-
vidual design would introduce the possibility of contam-
ination by participating physiotherapists in different arms3
2
1
1 2
Cl
us
te
r
Time
Figure 1 The stepped-wedge design for this study. Each cell represent
cells represent intervention periods.of the trial working together and discussing the inter-
vention. By clustering physiotherapists by department and
these clusters being the unit of randomisation, this risk of
contamination is minimized [75,77-79].
CRCTs can use parallel, crossover or stepped-wedge
designs [80], and the stepped wedge design was selected
for several reasons. First, there is not a belief of equi-
poise. That is, it is rational to believe that the interven-
tion is likely to result in good rather than harm for both
the participating physiotherapists, who will receive Master’s
level mentoring, and the clusters of patients ‘exposed’
to management by the physiotherapists who have
received training. This would make a parallel CRCT
ethically less acceptable in that it would withhold the
intervention from a larger proportion of physiothera-
pists and patients [81-83]. While a standard crossover
CRCT would also satisfy this ethical concern, it would
require the delivery of the intervention at the same
time. This is logistically and practically difficult, as the
intervention requires both specialist input and time
input, making the stepped-wedge design preferable as an
intervention that can be delivered in stages [81,83,84].
Second, the stepped-wedge design has been used to allow
detection of underlying trends or control for time effects
[81,83]. This is of interest in the current study, as the
multiple time points of data collection will allow for inves-
tigation of time effects to answer relevant questions. For
example, does the effect dissipate over time, or does the
intervention require time to consolidate and therefore
have impact on patient outcomes? Third, the stepped-
wedge design requires fewer clusters [84] than a parallel
CRCT, and it maximises power as the intervention effect3 4
 Period
s a data collection point. Red cells represent control periods and green
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comparisons [81].
The first step (time period 1) corresponds to a baseline
measurement where none of the clusters receive the
intervention. At each subsequent step, a cluster of
participating physiotherapists (two departments of the
musculoskeletal outpatient physiotherapy service) will
cross over from control to receive the intervention.
Participants
Eligibility criteria for participant clusters
All qualified physiotherapists working in the selected
National Health Service (NHS) organization whose
majority of time is practising in the musculoskeletal
outpatient context will be eligible to participate. Exclu-
sion criteria are physiotherapists who have already
undertaken work-based placements as part of Master’s
education, and rotational members of staff who will
not be present for the duration of the study. Informed
consent will be gained by approaching eligible physio-
therapists and issuing detailed written information;
those wishing to participate will give written consent,
and they will be free to withdraw from the study at any
time without giving reason.
Eligibility criteria for patient clusters
Consecutive consenting patients attending the outpatient
musculoskeletal physiotherapy service for treatment by
the participating physiotherapists during data collection
periods will be eligible to participate. Exclusion criteria are
patients under 18 years of age, and patients who are not
English-literate due to the validity of some of the selected
outcome measures being established only for the English
language and for adults [85-92]. Patients will receive their
normal care; written consent will be obtained for their
outcome data to be used for the purposes of the study.
Settings and locations where the data will be collected
Patient outcome data will be collected at the first and last
(discharge) appointment for physiotherapy treatment at
six outpatient sites for musculoskeletal physiotherapy
service delivery. The six sites will be organized into three
pairs for training purposes, and these pairs will form the
three clusters that will be the unit of randomisation as
illustrated below. While the outcome at discharge will be
the primary end point, patient outcome data at 12 months
post-discharge will inform long-term impact on patient
outcomes and assist in analysis of the cost-effectiveness of
the intervention.
Interventions
Intervention
The intervention is a 150-hour clinical mentorship pro-
gramme, aimed at facilitating clinical reasoning, basedon established practice in Master’s level courses in
musculoskeletal physiotherapy, in line with the educa-
tional standards document of IFOMPT [69]. The focus
on sound clinical reasoning for the educational inter-
vention is supported by the educational standards [69].
Furthermore, a recent study into the research priorities
for postgraduate theses in musculoskeletal physiother-
apy internationally [49], identified prioritised research
questions focused to clinical reasoning processes and
skills. A focus on clinical reasoning is also supported
by its highlighted importance in Master’s level clinical
practice in healthcare in the United Kingdom [48], and
specifically in Master’s level manipulative physiother-
apy [47]. The educational intervention will be delivered
to participating physiotherapists by mentors who are
members of the UK Member Organization of IFOMPT,
the Musculoskeletal Association of Chartered Physio-
therapists (MACP), having undertaken extensive post-
graduate study, having reached a recognised standard
of excellence in musculoskeletal physiotherapy and
having experience in delivering this form of mentor-
ship at the postgraduate level. Once baseline data
collection is completed in the first time period, the
intervention will be rolled out, to one cluster per time
period over the next three time periods. It will be delivered
at the start of the time period to allow for consolidation
and application of the programme before data collection
occurs at the end of the time period. The intervention
will take place in the usual clinical context of the par-
ticipating physiotherapists. It will consist of the mentors
observing the participating physiotherapists assessing
and treating new and follow-up patients, and discussing
and facilitating clinical reasoning processes immediately
after the patient encounter.
Control
During the control steps of the study design, partici-
pants will receive their usual training allocation. Usual
training for staff in the selected NHS organization in-
volves monthly in-service training on current evidence
applied to physiotherapy practice (4 hours per month),
weekly technique sessions on the technical and practical
skills of physiotherapy practice (30 minutes per week),
as well as monthly mentoring sessions (1½ hours per
month). While usual training does contain mentoring,
the content, delivery and volume of this mentoring
differs substantially from that of the intervention in that
while patient interactions may be observed, they fre-
quently take other forms, including practical skill teach-
ing, tutorials, and retrospective reviews of patients
using notes. Usual training allocates 1½ hours to men-
toring, delivered once a month. In comparison, the
intervention will allocate a much more intensive 150
hours of mentorship.
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Clusters of patients will receive their physiotherapy
treatment after the participating physiotherapists have
received either intervention or control educational
intervention. Patient outcome data will be collected at
baseline (time period 1) and at the end of each of the
subsequent three time periods (time periods 2 to 4) to
allow for the consolidation and application of the train-
ing (which will have been delivered at the start of the
time period).
Patient outcomes will be measured at the first visit,
final discharge visit (primary end point), and at 12
months post-discharge, using four patient reported
outcome measures. The primary outcome measure is
health-related quality of life (HRQL) measured with a
patient-specific tool, the Patient Specific Functional
Scale (PSFS). Secondary outcome measures include a
generic measure of HRQL (EQ-5D-5L), a measure of
the patients’ ability to self-manage (the Patient Activation
Measure (PAM)), and patient satisfaction (measured with
the MedRisk instrument for Measuring Patient Satis-
faction with Physical Therapy Care (MRPS)). In select-
ing appropriate outcome measures, three important
factors were considered [93] - selection of dimensions
to measure, psychometric properties, and practicality.
The selection of dimensions to measure were influenced
by the WHO’s International Classification of Func-
tioning, Disability and Health (ICF) framework [94] for
measuring health and disability at both individual and
population levels [95-100].
The PSFS, a patient-specific HRQL measure, was
selected as the primary outcome measure for its
responsiveness [85,101,102] and psychometric properties
(validity studies provide data on the minimal detectable
change and the minimal clinically important difference
across body regions [85,87,103-110], practicality [103] and
dimensions selected for measurement, corresponding to
the ICF dimensions of activity and participation being
measured [111,112]). The Euroqol (EQ-5D-5L) is the
generic instrument selected to measure HRQL on the
basis of its broad application to a wide range of health
conditions and treatments and its provision of a simple
descriptive profile and single index value for health
status [113-118], which is appropriate for the variety of
patients with different musculoskeletal conditions used
in this study. The PAM will be used for the assessment
of patient self-efficacy on the basis that one of the
primary goals of rehabilitation is the enhancement of
patient’s ability and confidence to manage their own
health, which may not be fully captured by discharge
functional or health related quality of life measures [37].
The PAM has undergone multiphase psychometric test-
ing to confirm its validity and reliability and its ability
to maintain precision across different demographic andhealth status groups [90,91,119-125]. Patient satisfaction
will be measured, as one of the key features of develop-
ment in expertise in clinical reasoning is collaborative
reasoning [42,43,45] where patient centred care is seen
as integral to practice. Moves towards patient centred
care have seen the growth of interest in measurement of
patient satisfaction as an important outcome measure
in healthcare research [126,127]. The MRPS will be used
on the basis of its psychometric properties, its valid-
ation for use in an outpatient physiotherapy environ-
ment, its user-friendliness, and its satisfaction on the
criteria identified by several authors exploring suitable
patient satisfaction questionnaires [92,127-133].
Physiotherapist performance will be assessed by an
independent, blinded assessor who works outside of
the NHS organization where the research is being
conducted. This assessment of performance will be made
using the criteria used by a UK academic institution
experienced in the assessment of Master’s level post-
graduate student performance in the musculoskeletal
context. The independent assessor is educated to Mas-
ter’s level and is MACP qualified, with several years
experience of Master’s level mentoring, as well as ex-
perience in using the same criteria for assessment
purposes.
Sample size
Sample size calculations, using conventional values of
0.80 for statistical power and 0.05 for statistical signifi-
cance, were performed following the approached out-
lined for stepped-wedge designs in Hussey and Hughes
[84]. For a realistic sample of 12 participating physio-
therapists, who will be organized into three clusters,
and setting an intergroup difference of 1.0 on the PSFS
with a standard deviation of 2.0 (based on previous
patient data from the NHS organization and values of
PSFS outcomes from published studies [87,102,134]),
ten patients are required to complete the outcome
measures per physiotherapist at each of the four time
points. This will result in a total sample size of 480 sets of
patient outcomes. In order to ensure a robust research
protocol to ensure that adequate power is achieved, loss to
follow-up rates were anticipated to be 33% at worst (based
on data from the same organization from previous out-
come collection), and the number of patients complet-
ing outcomes per physiotherapist per time point was
revised to 15 to allow for this anticipated loss. The total
required sample size was therefore established as 720
patients (that is, 12 physiotherapists collecting outcome
measures from 15 patients at each of four time points).
Randomisation and blinding
In stepped-wedge trials, the timing of intervention
rollout is the unit of randomisation. The participating
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mentoring interventions will be aware of which cluster is
receiving the intervention [81,82]. The clusters of par
ticipating physiotherapists (clustering by site) will be ran-
domly allocated to the sequence of intervention (to receive
the intervention in time period 2, 3 or 4), by computer
programme [135]. This process will be performed by one
of the clinical mentors, who will also allocate a unique
identification code to each physiotherapist that will be
included on all outcome measure questionnaires. The
clinical mentor will keep a sealed copy of the key code
linking codes to physiotherapists and will send a sealed
copy of the key code to the academic institution respon-
sible for trial governance.
The key code will only be opened once all outcome
data have been collected and analyzed from each of
the four time points. These processes will ensure allo-
cation concealment and the blinding of the lead re-
searcher to the sequence generation and intervention
allocation. The independent assessor of physiotherap-
ist performance will be blinded as to whether the
physiotherapist has received the intervention during
their assessment. Patients will also be blinded to whether
or not their treating physiotherapist has received the
intervention.
Statistical methods
The statistical analysis of the stepped-wedge design has
been an area of debate in the literature as analysis is
said to be complex due to the need to account for
repeated measures on the same individual and control
for trends in outcome variables due to passage of time
[81]. Indeed, in one systematic review of stepped-
wedge CRCTs, the heterogeneity of analytical methods
applied was seen as a weakness of some of the reviewed
studies [83]. A standardised approach to analysis is
recommended by the two systematic reviews. Such a
standardized analysis of stepped-wedge trials has been
clearly outlined in a published paper [84] and recom-
mends processes for analysis of cluster-level means and
individual level analysis in scenarios where cluster sizes
are equal or unequal, and where variance is known or
unknown. Processes for between-cluster and within-
cluster analyses are outlined in order to avoid con-
founding the treatment effect with changes over time;
these processes will form the basis for the statistical
analysis for the study. If no temporal effects are found
influencing the outcome, then a within-cluster analysis
can be used to estimate the treatment effect. The
proposed statistical analysis will involve classical linear
models (so observations belong to control or inter-
vention groups, differentiated by a single intervention
effect), incorporating a random intercept term to reflect
any systematic differences between clusters. Similarstatistical methods have been used in other published
stepped-wedge trials [81,136,137].
The use of aggregate differences in PSFS scores has
been advocated and used in studies [134,138], but has
also been criticized [88,139] on the basis that validity
studies of the PSFS have been primarily related to
changes in individual patients. These studies, however,
also give important data on the minimal detectable
change (MDC) and the minimal clinically important
difference (MCID), which are both reported to be three
points for each identified activity and two points for
aggregate activities. This data is helpful, as analysis in
this study will also look at the number or proportion of
patients achieving significant changes in PSFS out-
comes. This would require analysis of binary data,
attributing 0/1 values to patients who do or do not
achieve MDC/MCID. The convention for assessing the
effect of clustering on binary variables is to assume
normality and apply the usual linear models [140].
Ethical approval
Ethical approval for the study was sought and obtained
from the South East Wales Research Ethics Committee
C on 20/04/2012 (ref: 12/WA/0078).
Discussion
Stepped-wedge designs afford many advantages as out-
lined above. There are, however, limitations to this
design, which are strongly emphasised by one group of
authors in making their case for the superiority of stand-
ard parallel CRCTs [141]. The understanding of these
disadvantages is not new, having been highlighted in two
previous systematic reviews [81,83] and reiterated in
response to this criticism [142]. The limitations of the
design are that the stepped-wedge design will take
longer to conduct than a standard CRCT (due to the
phased introduction of the intervention), the repeated
measurements of the dependent variable increase the
burden on participants and researchers, the potential
risk of contamination or attrition in participants from a
cluster due to receive the intervention at one of the later
steps, and that an intervention is implemented in all
clusters of the trial when it has not yet been proven to
be effective. These points are important to address to
clarify why the stepped wedge-design was selected over
a standard parallel CRCT design for this trial.
The first point about the duration of the trial, and the
associated point of attrition as a result of this, is well
made. However, this trial is taking place in the real
world of clinical practice, where normal service delivery
and targets must still be met. While a standard parallel
CRCT would reduce the time and potential attrition, it
would be impractical for two reasons related to the
intervention being delivered. First, the time factors
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impact of introducing the intervention simultaneously
across multiple clusters far greater on the capacity of
the musculoskeletal physiotherapy service to deliver
usual care across different clinics and venues. By rolling
out the intervention across different time points,
greater flexibility is afforded to organize clinic cover,
allowing the participants to receive the intervention
without compromise to the delivery of usual musculo-
skeletal service delivery commitments. Indeed, when
negotiating the implementation of the RCT, the senior
management within the organization made clear that
the loss of the agreed clinical commitments required by
a parallel CRCT would be unacceptable. Secondly, the
delivery of the intervention is by mentors who have
qualified at Master’s level, having received such men-
toring as part of their postgraduate education, as well
as delivering mentoring in this format to Master’s level
students. Such a finite resource makes a standard parallel
CRCT impractical, whereas the rolling out of the inter-
vention in the stepped-wedge design utilises the avail-
able mentors in a way that makes this CRCT feasible.
Although the repeated measurements of a stepped-
wedge design may create a burden on participants,
similar measures are already collected regularly by the
participants as standard clinical practice within the
musculoskeletal physiotherapy service for its annual
service evaluation process. The final point - that an
intervention is implemented in all clusters of the trial
when it has not yet been proven to be effective - is
recognised as being valid in certain contexts. However,
in the context of this trial, patients will receive their
usual physiotherapy, and participating physiotherapists
will receive an intervention for which there is already
qualitative research supporting the impact of change
in physiotherapist performance. Indeed, it could be
argued that in a parallel CRCT, attrition from the
control group could be greater than in the stepped-
wedge CRCT design, as participating physiotherapists
would in all likelihood concur that it is rational to
believe that the intervention is likely to result in good
rather than harm as discussed above.
In addition, the two systematic reviews raised further
issues regarding the reporting and analysis of stepped-
wedge CRCTs. A lack of fulfilment of the methodo-
logical requirements for a controlled trial, a lack of
blinding of those assessing outcomes and heterogeneity of
analytical methods applied were the key weaknesses
identified. This led to the reviewers making the follow-
ing recommendations for the reporting and analysis of
stepped wedge CRCTs. First, authors should register
their trial on the Controlled Clinical Trials Register
and follow appropriate reporting guidelines; second,
ways should be explored for enhancing internal validitythrough blinding of outcome assessors where possible
and for the use of adequate sequence generation and
allocation concealment; and third, standard methods of
analysis should be used. The current study has been
registered with Current Controlled Trials, and CON-
SORT and SPIRIT guidelines have been used in the
protocol write-up. Sequence generation will be per-
formed by one of the clinical mentors, randomly allo-
cating the clusters of physiotherapists to the sequence
of intervention by computer programme [135]. The
allocated mentor will ensure that the sequence alloca-
tion is adequately concealed from the lead researcher,
as all patient outcome data will be coded, the key code
for which will be sealed and given to the academic
institution responsible for the academic supervision of
this research and not revealed until after the data
collection and analysis period is completed. These
measures for blinding, sequence generation and allo-
cation concealment are implemented to reduce the
risk of bias, as highlighted by the Cochrane risk of bias
tool [143,144]. With regard to statistical aspects, the
approached outlined by Hussey and Hughes [75] for
the design and analysis of stepped-wedge CRCTs has
been adopted for sample size calculations and will be
followed for analysis of the study data.
Through this RCT, the effectiveness of this mentoring
programme for physiotherapists in the workplace to
achieve better clinical outcomes for their patients will
be evaluated. Specifically, this will allow the exploration
of whether there are potential benefits to using such
a training programme on a larger scale, as well as
contributing to the body of literature on education and
outcomes.
Trial status
At the time of manuscript submission, the RCT had
begun patient recruitment, which will not be complete
until 2015.
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